Stuart E. Pearson

1.0k total citations
13 papers, 330 citations indexed

About

Stuart E. Pearson is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Stuart E. Pearson has authored 13 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Stuart E. Pearson's work include Quinazolinone synthesis and applications (4 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer therapeutics and mechanisms (2 papers). Stuart E. Pearson is often cited by papers focused on Quinazolinone synthesis and applications (4 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer therapeutics and mechanisms (2 papers). Stuart E. Pearson collaborates with scholars based in United Kingdom, France and Sweden. Stuart E. Pearson's co-authors include James S. Scott, Santosh Nandan, Stephen Caddick, Ryan Greenwood, F. Geoffrey N. Cloke, Kevin Hudson, Richard J. Fitzmaurice, Michael Mrosek, David Whittaker and Jon Winter and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Journal of Organometallic Chemistry.

In The Last Decade

Stuart E. Pearson

13 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart E. Pearson United Kingdom 9 179 165 71 45 38 13 330
Ryan Greenwood United Kingdom 10 312 1.7× 209 1.3× 79 1.1× 73 1.6× 72 1.9× 18 517
Susan L. Hockerman United States 8 283 1.6× 211 1.3× 81 1.1× 84 1.9× 17 0.4× 9 461
Ramakrishna Edupuganti United States 15 336 1.9× 167 1.0× 69 1.0× 91 2.0× 28 0.7× 19 495
Mark Charles United Kingdom 8 205 1.1× 247 1.5× 75 1.1× 43 1.0× 13 0.3× 9 498
Zhen‐Wei Cai United States 10 148 0.8× 168 1.0× 30 0.4× 58 1.3× 22 0.6× 14 339
Jon Winter United Kingdom 8 282 1.6× 158 1.0× 72 1.0× 38 0.8× 70 1.8× 11 434
Anna I. Koutsourea Greece 13 198 1.1× 226 1.4× 30 0.4× 66 1.5× 33 0.9× 22 377
Donald W. Andisik United States 9 194 1.1× 208 1.3× 45 0.6× 57 1.3× 27 0.7× 12 355
Leonard R. Hecker United States 12 240 1.3× 302 1.8× 30 0.4× 35 0.8× 39 1.0× 14 508
Kristen L. Arienti United States 8 210 1.2× 117 0.7× 26 0.4× 82 1.8× 17 0.4× 8 364

Countries citing papers authored by Stuart E. Pearson

Since Specialization
Citations

This map shows the geographic impact of Stuart E. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart E. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart E. Pearson more than expected).

Fields of papers citing papers by Stuart E. Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart E. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart E. Pearson. The network helps show where Stuart E. Pearson may publish in the future.

Co-authorship network of co-authors of Stuart E. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart E. Pearson. A scholar is included among the top collaborators of Stuart E. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart E. Pearson. Stuart E. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Cumming, Iain, Sébastien L. Degorce, Anna Aagaard, et al.. (2022). Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors. Bioorganic & Medicinal Chemistry. 63. 116729–116729. 4 indexed citations
2.
Barlaam, Bernard, Elaine Cadogan, Andrew D. Campbell, et al.. (2018). Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors. ACS Medicinal Chemistry Letters. 9(8). 809–814. 19 indexed citations
3.
Pearson, Stuart E., et al.. (2018). Synthesis of Indole-Dihydroisoquinoline Sulfonyl Ureas via Three-Component Reactions. Synthesis. 50(24). 4963–4981. 4 indexed citations
4.
Goldberg, Frederick W., et al.. (2016). Identification and optimisation of a series of N-(4-anilino-2-pyridyl)acetamide activin receptor-like kinase 1 (ALK1) inhibitors. MedChemComm. 7(6). 1204–1208. 6 indexed citations
5.
Pike, Kurt G., Jeff Morris, Linette Ruston, et al.. (2015). Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2. Journal of Medicinal Chemistry. 58(5). 2326–2349. 25 indexed citations
6.
Ward, Richard A., C. Brassington, Alexander L. Breeze, et al.. (2012). Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation. Journal of Medicinal Chemistry. 55(7). 3285–3306. 126 indexed citations
7.
Cloke, F. Geoffrey N., et al.. (2008). Development of a practical Buchwald–Hartwig amine arylation protocol using a conveniently prepared (NHC)Pd(R-allyl)Cl catalyst. Organic & Biomolecular Chemistry. 6(15). 2820–2820. 39 indexed citations
8.
Ballard, Peter, Bernard Barlaam, Robert H. Bradbury, et al.. (2007). Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 17(22). 6326–6329. 23 indexed citations
9.
Barlaam, Bernard, Peter Ballard, Robert H. Bradbury, et al.. (2007). A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 18(2). 674–678. 18 indexed citations
10.
Ballard, Peter, Robert H. Bradbury, Craig S. Harris, et al.. (2006). Inhibitors of epidermal growth factor receptor tyrosine kinase: Optimisation of potency and in vivo pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 16(18). 4908–4912. 29 indexed citations
11.
Cloke, F. Geoffrey N., et al.. (2005). Studies on Pd/imidazolium salt protocols for aminations of aryl bromides and iodides using lithium hexamethyldisilazide (LHMDS). Journal of Organometallic Chemistry. 690(24-25). 5841–5848. 16 indexed citations
12.
Pearson, Stuart E. & Santosh Nandan. (2005). A Practical, Efficient Synthesis of 5-Amino-7-azaindole. Synthesis. 2005(15). 2503–2506. 19 indexed citations
13.
Pearson, Stuart E. & Robin Wood. (2002). The ‘Eenie–Meenie reaction’. Displacement reactions of bisanilinopyrimidines. Tetrahedron Letters. 43(7). 1303–1306. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026